TNF-Related Apoptosis-Inducing Ligand Receptor 1 in Patients With Ankylosing Spondylitis
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, cilt.26, sa.6, ss.242-247, 2020 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 26 Sayı: 6
- Basım Tarihi: 2020
- Doi Numarası: 10.1097/rhu.0000000000001050
- Dergi Adı: JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
- Sayfa Sayıları: ss.242-247
- Anahtar Kelimeler: TNF-related apoptosis-inducing ligand receptor 1, TNF-alpha, ankylosing spondylitis, INCREASED EXPRESSION, TRAIL, CYTOKINES, THERAPY
- Kocaeli Üniversitesi Adresli: Evet
Özet
Objectives: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) belongs to the tumor necrosis factor (TNF) superfamily and is reported to play a role in autoimmune diseases. In this study, we aimed to measure serum TRAIL receptor 1 (TRAIL-R1) concentration and assess any phenotypic relationship in patients with ankylosing spondylitis (AS).